Skip to Content
Morningstar

Debbie Wang

Debbie Wang is a senior equity analyst for Morningstar.

More From Debbie Wang

It's once again leading the field in the technology for treatment-resistant hypertension.
Debbie Wang

With consistency that we rarely see in medical technology, Stryker has delivered another quarter of strong growth across all three of its segments.
Debbie Wang

Diagnostic testing, treatment, and a coronavirus vaccine could allow near-normal distancing and nonessential business recovery by mid-2021.
Karen Andersen, CFA

More About Debbie Wang

Debbie Wang is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers the medical-device, diagnostics, and animal health industries. Previously, she was an associate director of equity analysis for Morningstar, leading the healthcare team.

Before joining Morningstar in 2002, Wang was a vice president and senior brand strategist for Leo Burnett. During her tenure at Leo Burnett, she led brand strategy on a variety of accounts, including Allstate, Amoco, McDonald's, Heinz, Smucker’s, Pepto-Bismol, and Celebrex.

Wang holds a bachelor’s degree in anthropology from Colgate University and a master’s degree in business administration from the University of Chicago Booth School of Business.

Sponsor Center